NICOX SA (ALCOX.PA) Fundamental Analysis & Valuation
EPA:ALCOX • FR0013018124
Current stock price
0.407 EUR
0 (0%)
Last:
This ALCOX.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ALCOX.PA Profitability Analysis
1.1 Basic Checks
- ALCOX had negative earnings in the past year.
- In the past 5 years ALCOX always reported negative net income.
- ALCOX had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of -185.23%, ALCOX is doing worse than 88.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -185.23% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-53.63%
ROA(5y)-42.36%
ROE(3y)-268.82%
ROE(5y)-176.47%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- ALCOX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. ALCOX.PA Health Analysis
2.1 Basic Checks
- ALCOX has more shares outstanding than it did 1 year ago.
- ALCOX has more shares outstanding than it did 5 years ago.
- ALCOX has a worse debt/assets ratio than last year.
2.2 Solvency
- ALCOX has an Altman-Z score of -58.81. This is a bad value and indicates that ALCOX is not financially healthy and even has some risk of bankruptcy.
- ALCOX's Altman-Z score of -58.81 is on the low side compared to the rest of the industry. ALCOX is outperformed by 91.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -58.81 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- A Current Ratio of 10.66 indicates that ALCOX has no problem at all paying its short term obligations.
- Looking at the Current ratio, with a value of 10.66, ALCOX belongs to the top of the industry, outperforming 94.44% of the companies in the same industry.
- ALCOX has a Quick Ratio of 10.66. This indicates that ALCOX is financially healthy and has no problem in meeting its short term obligations.
- ALCOX has a Quick ratio of 10.66. This is amongst the best in the industry. ALCOX outperforms 94.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 10.66 | ||
| Quick Ratio | 10.66 |
3. ALCOX.PA Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 22.64% over the past year.
- The Revenue has grown by 13.85% in the past year. This is quite good.
- Measured over the past years, ALCOX shows a small growth in Revenue. The Revenue has been growing by 2.77% on average per year.
EPS 1Y (TTM)22.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-81.98%
Revenue 1Y (TTM)13.85%
Revenue growth 3Y2.8%
Revenue growth 5Y2.77%
Sales Q2Q%-74.85%
3.2 Future
- ALCOX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 58.75% yearly.
- The Revenue is expected to grow by 102.03% on average over the next years. This is a very strong growth
EPS Next Y96%
EPS Next 2Y58.75%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year230%
Revenue Next 2Y102.03%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. ALCOX.PA Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for ALCOX. In the last year negative earnings were reported.
- ALCOX is valuated cheaply with a Price/Forward Earnings ratio of 3.04.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of ALCOX indicates a rather cheap valuation: ALCOX is cheaper than 100.00% of the companies listed in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 22.29, ALCOX is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 3.04 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- ALCOX's earnings are expected to grow with 58.75% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y58.75%
EPS Next 3YN/A
5. ALCOX.PA Dividend Analysis
5.1 Amount
- No dividends for ALCOX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ALCOX.PA Fundamentals: All Metrics, Ratios and Statistics
EPA:ALCOX (4/24/2026, 7:00:00 PM)
0.407
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)N/A N/A
Earnings (Next)04-28 2026-04-28/amc
Inst Owners4.12%
Inst Owner ChangeN/A
Ins Owners0.33%
Ins Owner ChangeN/A
Market Cap36.00M
Revenue(TTM)3.32M
Net Income(TTM)-27.06M
Analysts84.44
Price Target1.53 (275.92%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 3.04 | ||
| P/S | 10.86 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.37
EYN/A
EPS(NY)0.13
Fwd EY32.9%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.04
BVpS-0.05
TBVpS-0.05
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -185.23% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-53.63%
ROA(5y)-42.36%
ROE(3y)-268.82%
ROE(5y)-176.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.23
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 10.66 | ||
| Quick Ratio | 10.66 | ||
| Altman-Z | -58.81 |
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-81.98%
EPS Next Y96%
EPS Next 2Y58.75%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)13.85%
Revenue growth 3Y2.8%
Revenue growth 5Y2.77%
Sales Q2Q%-74.85%
Revenue Next Year230%
Revenue Next 2Y102.03%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-106.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year67.32%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A
NICOX SA / ALCOX.PA Fundamental Analysis FAQ
What is the ChartMill fundamental rating of NICOX SA (ALCOX.PA) stock?
ChartMill assigns a fundamental rating of 3 / 10 to ALCOX.PA.
What is the valuation status for ALCOX stock?
ChartMill assigns a valuation rating of 4 / 10 to NICOX SA (ALCOX.PA). This can be considered as Fairly Valued.
Can you provide the profitability details for NICOX SA?
NICOX SA (ALCOX.PA) has a profitability rating of 0 / 10.
What is the earnings growth outlook for NICOX SA?
The Earnings per Share (EPS) of NICOX SA (ALCOX.PA) is expected to grow by 96% in the next year.